Human FCRL5 Antibody Summary
Accession # Q96RD9
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of FCRL5/FCRL3 in Human Lymphocytes by Flow Cytometry. Human blood‑derived lymphocytes were stained with (A) Mouse Anti-Human FCRL5 Monoclonal Antibody (Catalog # MAB20872) or (B) Mouse IgG1 isotype control antibody (Catalog # MAB002), followed by Allophycocyanin-conjugated Anti-Mouse IgG F(ab')2 Secondary Antibody (Catalog # F0101B) and PE-conjugated Mouse Anti-Human CD19 Monoclonal Antibody (Catalog # FAB4867P).
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Fc Receptor-Like 5 (FCRL5), also known as FcRH5, IRTA2, and CD307, is a 120 kDa protein with sequence homology to classical Fc receptors. The type 1 transmembrane FCRL proteins contain from three to nine immunoglobulin-like domains. They are differentially expressed within the B cell lineage and can either promote or inhibit B cell proliferation and activation (1, 2). According to R&D Systems testing, FCRL5 binds to purified human IgG with high affinity. Mature human FCRL5 consists of a 836 amino acid (aa) extracellular domain (ECD) with nine Ig-like domains, a 21 aa transmembrane segment, and a 105 aa cytoplasmic domain with one immunotyrosine activation motif (ITAM) and two immunotyrosine inhibitory motifs (ITIMs) (1, 3). Mouse FCRL5 contains only five Ig-like domains in its ECD. It shares 49% aa sequence identity with human FCRL5 within common regions. Alternate splicing of human FCRL5 generates isoforms that consist of approximately the first one, six, or eight Ig-like domains (3, 4). FCRL5 expression is restricted to mature B lineage cells in lymphoid tissues and blood (3, 5‑7). Its ligation inhibits signaling through the B cell antigen receptor (8). Epstein-Barr virus transformation of B cells induces the up‑regulation of surface FCRL5 by a direct effect of its EBNA2 protein on FCRL5 gene transcription (9). The FCRL5 gene maps to the 1q21 chromosomal locus, a common site of rearrangements in B cell malignancies, and the FCRL5 protein is preferentially expressed in cell lines with 1q21 abnormalities (3). FCRL5 is up‑regulated on tumor cells in some types of B cell malignancies (6, 10‑12). In addition, soluble FCRL5 is elevated in the serum of many B cell leukemia patients (11, 13).
- Davis, R.S. (2007) Annu. Rev. Immunol. 25:525.
- Maltais, L.J. et al. (2006) Nat. Immunol. 7:431.
- Hatzivassiliou, G. et al. (2001) Immunity 14:277.
- SwissProt # Q96RD9.
- Miller, I. et al. (2002) Blood 99:2662.
- Polson, A.G. et al. (2006) Int. Immunol. 18:1363.
- Vidal-Laliena, M. et al. (2005) Cell. Immunol. 236:6.
- Haga, C.L. et al. (2007) Proc. Natl. Acad. Sci. 104:9770.
- Mohan, J. et al. (2006) Blood 107:4433.
- Ise, T. et al. (2005) Clin. Cancer Res. 11:87.
- Ise, T. et al. (2007) Leukemia 21:169.
- Kazemi, T. et al. (2009) Cancer Immunol. Immunother. 58:989.
- Ise, T. et al. (2006) Clin. Chem. Lab. Med. 44:594.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human FCRL5 Antibody
There are currently no reviews for this product. Be the first to review Human FCRL5 Antibody and earn rewards!
Have you used Human FCRL5 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image